Literature DB >> 8071381

Synthetic scleral reinforcement materials: I. Development and in vivo tissue biocompatibility response.

J T Jacob-LaBarre1, M Assouline, T Byrd, M McDonald.   

Abstract

The surgical treatment of pathological myopia involves the placement of a band cut from donor sclera around the back of the globe to provide support and to prevent elongation that leads to retinal detachment and blindness. In the search for a synthetic material that would overcome the disadvantages of the donor tissue band, we tested 11 types of bands made from 14 polymers in rabbit eyes. Bands were cut from porous and solid materials, as well as porous materials coated with solids and solid materials with porous patches affixed to the posterior surface. Criteria for suitability and biocompatibility included ease of placement and suturing, stable positioning, and absence of long-term tissue response on a cellular level. Testing included evaluation by the surgeons performing the implantations, measurement of the distance between the band and the globe, determination of fibrous capsule thickness and amount of collagen deposition, and enumeration of macrophages accumulated at the band/capsule interface. Based on the results of these studies, two of the porous materials (expanded polytetrafluoroethylene and porous polyurethane fabric) and two of the composite materials (porous polyurethane fabric coated with polyacrylonitrile and silicone with microvilli cut into the posterior surface) were selected for further study.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8071381     DOI: 10.1002/jbm.820280607

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  2 in total

1.  The soft keratoprosthesis.

Authors:  D R Caldwell
Journal:  Trans Am Ophthalmol Soc       Date:  1997

2.  Intrascleral outflow after deep sclerectomy with absorbable and non-absorbable implants in the rabbit eye.

Authors:  Jakub J Kałużny; Dariusz Grzanka; Halina Wiśniewska; Alicja Niewińska; Bartłomiej J Kałużny; Alina Grzanka
Journal:  Med Sci Monit       Date:  2012-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.